Expansion into pancreatic cancer

The first pancreatic cancer samples were received from Sahlgrenska University Hospital in Sweden. Dr. Elena Rangelova is the principal investigator and the aim is to develop co-culture for in vitro diagnostic purposes.

We have successfully established the first pancreatic cancer models as part of the INVICTA-study. Surgeon Dr. Elena Rangelova is the principal investigator and the aim is to develop co-culture for in vitro diagnostic purposes. Developing precision medicine is a multi-disciplinary effort, and we are grateful for the support from clinical collaborators – and not at least their patients.